~~<i id='8E98F21E7D'><strike id='8E98F21E7D'><tt id='8E98F21E7D'><pre id='8E98F21E7D'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

leisure time

author：leisure time 2025-09-05 11:27:59 - browse：5

JUUL store sign -- health coverage from STAT — Stephanie Keith/Getty Images

Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

It’s not clear how much the company ultimately spent on the partnerships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： 23andMe had bad news about my health. I wish a person had delivered it
Next article： Surprise medical billing ban raises prices elsewhere

entertainment

leisure time

focus

entertainment

explore

knowledge

MollyFergusonforSTATHerearetwothingsthataretrue.Theworldneedsmoreeffectivefluvaccines.Andpharmaceuti

WSS

J&J to emphasize cancer drugs, stop much of its vaccine research

A new drug could help frostbite victims avoid its ravages

ReNAgade cuts staff seven months after raising $300 million

Weight loss drugs aren’t covered by Obamacare. That may change

Abridge raises $150m as clinical notes automation market heats up

ReNAgade cuts staff seven months after raising $300 million

hotspot

leisure time

entertainment

How one medical school became remarkably diverse

Hospitals are piloting generative AI tools as regulators play catch

Hollywood unions extend contract negotiations for actors

Researchers tackle phage therapy hurdles for wider adoption

BioMarin wins approval for gene therapy to treat hemophilia A

Takeda, Janssen join wearable maker to measure scratching

Wildfire smoke exposes gaps in outdoor worker protections

Rep. Raul Ruiz on the physician shortage and more

Jerome Adams on the need for new antivirals for Covid

BIO selects John Crowley as new CEO

leisure time

AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

Takeda, Janssen join wearable maker to measure scratching

CDC director unscathed in first congressional testimony

Medicare Advantage enrollment hits roughly 33.4 million

Diagnostic tests are hitting their mathematical limits

Cigna, Humana reportedly in talks to merge

focus

entertainment

explore

knowledge